Prot: IM011073: A Phase 2, Randomized, Double-blind, Placebo-controlled Evaluation of the Safety and Efficacy of BMS-986165 with Background Treatment in Subjects with Lupus Nephritis

Project: Research project

Project Details

StatusActive
Effective start/end date9/9/199/9/22

Funding

  • Pharmaceutical Research Associates, Inc. (Prot: IM011073)
  • Bristol-Myers Squibb Company (Prot: IM011073)